New technologies in cancer Research


Cancer research ranges from epidemiology, molecular bioscience to the performance of clinical trials to evaluate and compare applications of the various cancer treatments. These applications include surgery, radiation therapy, chemotherapy, hormone therapy, and immunotherapy and combined treatment modalities such as chemo-radiotherapy. Starting in the mid-1990s, the emphasis in clinical cancer research shifted towards therapies derived from biotechnology research, such as cancer immunotherapy and gene therapy.

Journal of Cancer Immunology and Therapy is an academic journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide. The journal selects the articles to be published with a single bind, peer review system, following the practices of good scholarly journals. It supports the open access policy of making scientific research accessible to one and all.

We are glad to invite all the esteemed authors to expertise their research in the field of cancer immunology. Our Editorial Board members are over whelmed by the response and eagerness of the academic and research contributors to publish with the journal and take part in submissions of the scientific work in the mode of manuscripts. During this year we look forward to taking some initiatives that would encourage and reward our prospective audience which include clinicians, research scientists, decision-makers and a range of professionals in the healthcare community.

Our Journal welcomes submissions of manuscripts on the topics within the scope of the journal. Manuscripts can be submitted as an attachment to

Media Contact,

Shelley Brown

Journal of Cancer Immunology and Therapy


WhatsApp: +1-97-333-4405